Processa Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

Supplemental Cash Flow Information, Disclosure: Schedule of Cash Flow, Supplemental Disclosures (Tables)

3 Months Ended

Mar. 31, 2016

	Three Months ended March 31,
	2016		2015
Cash paid for interest	$	5,211	$	12,557
Cash paid for income taxes	$	--	$	--

Non-Cash investing and financing transactions
Shares issued for consulting services	$	--	$	25,500